GO2 For Lung Cancer
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$17,189,128
Investments
32%
Cash & Equivalents
23%
Other Assets
21%
Receivables (Non-Related)
19%
Property, Plant, & Equipment (net)
4%
Prepaid Expenses
1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$5,673,989
Other Liabilities
82%
Payables & Accruals
18%
Deferred Revenue
<1%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$7,804,682
$4,006,534
-49%
Receivables (Non-Related)
$3,830,763
$3,316,589
-13%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$120,125
$185,425
+54%
Investments
$5,637,032
$5,456,405
-3%
Property, Plant, & Equipment (net)
$732,366
$633,961
-13%
Other Assets
$2,838,476
$3,590,214
+26%
Total Assets
$20,963,444
$17,189,128
-18%
Liabilities
2023
2024
Change
Payables & Accruals
$744,642
$994,808
+34%
Grants Payable
-
-
-
Deferred Revenue
$16,405
$22,250
+36%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$3,980,112
$4,656,931
+17%
Total Liabilities
$4,741,159
$5,673,989
+20%
Net assets
2023
2024
Change
Restricted Net Assets
$13,772,126
$7,319,615
-47%
Unrestricted Net Assets
$2,450,159
$4,195,524
+71%
Net assets
2023
2024
Change
Net assets
+$16,222,285
+$11,515,139
-29%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)